Clinicians use cross-sectional imaging to estimate the volume of liver that will remain after the planned resection. They then relate that estimate to total liver volume or to the patient’s body size. This calculation provides a quantitative basis for judging whether the proposed operation leaves an adequate reserve for safe recovery.
Remnant volume does not fully represent functional reserve when the remaining liver is diseased or injured. Cirrhosis, steatosis, and chemotherapy-related damage can reduce how well the liver performs after resection. Therefore, clinicians interpret the size estimate alongside liver condition rather than treating volume alone as a complete measure of safety.
Portal vein embolization redirects blood flow away from the portion of liver planned for removal and toward the intended remnant. This altered flow stimulates hypertrophy, or growth, of the future remnant before surgery. The approach can help when initial assessment indicates that the predicted remnant may be inadequate for a safe hepatectomy.
Assessment must account for both the amount of liver remaining and the condition of that tissue. Cirrhosis and steatosis may limit functional reserve, while prior chemotherapy can also injure the liver. These factors can change the safety of the same planned resection, making remnant evaluation an individualized rather than purely anatomical decision.
The process begins with cross-sectional imaging to estimate the portion that would remain after tumor resection. Clinicians compare its volume with total liver volume or body size, then adjust interpretation for cirrhosis, steatosis, or chemotherapy-related injury. If the predicted remnant is inadequate, portal vein embolization may be used before proceeding to surgery.
Future liver remnant assessment is especially important when treating liver tumors that require substantial hepatectomy. It helps the team judge whether the planned operation is feasible, identify a need for preoperative portal vein embolization, and tailor treatment to the patient’s liver condition. The overall goal is to reduce the risk of post-hepatectomy liver failure.